Advertisement
Advertisement
Trending on Urology Times
1
Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer
2
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
3
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
4
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
5


